about
Advances and challenges in the management of complement-mediated thrombotic microangiopathiesMutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.Thienopyridine-linked thrombotic microangiopathy: association with endothelial cell apoptosis and activation of MAP kinase signalling cascades.Thrombotic microangiopathy after kidney transplantation.Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosisPlasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.Haemolytic uraemic syndrome after living-donor liver transplantation: is small-for-size graft a potential risk factor?Multifaceted hemolytic uremic syndrome in pediatrics.Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.Dose kidney transplant nephrectomy stop disease progression in plasma exchange resistant post transplant hemolytic uremic syndrome? A case report.Shigella sonnei and hemolytic uremic syndrome: A case report and literature review.Post transplant thrombotic microangiopathy causing acute renal failureComplement related kidney diseases: Recurrence after transplantation.Thrombotic microangiopathy in renal allografts.Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination.Thrombotic microangiopathy after renal transplantation: Current insights in and recurrent disease
P2860
Q26796453-DA0DF41F-C1FC-4F95-8F31-6476F215A991Q33357218-6AA29459-E38E-4C5A-9F67-C1BD37544E30Q33358266-317243C2-C5FE-44CB-8B02-0FACC06D5729Q33372586-309EC90E-B8F2-46EC-A893-D0F4C03AC23EQ33378957-EA9F383F-F8CA-45A8-AE91-515D8FA1A2D2Q33379624-43F01E17-1B7B-4AA8-A789-2C3ABE07E074Q33379884-B461C930-4FC8-4278-AF1B-DF64246AEB7CQ33405452-0CC8ED6B-6578-4273-83BE-FA49C16B77E6Q33409586-3E6077CA-91BC-40DD-87B1-45BC9443CBABQ33413018-7F6DE03A-3300-4C00-BD98-C523CFD01E3BQ33439653-2B4E9872-398E-40C8-97B1-D2322378ACF6Q33762761-4A7B1914-7249-4B2E-83CA-FE2C4706B4EBQ37522557-B5F79583-B4E9-4C3D-8E40-0F34ED42B1F7Q37589777-959676E8-17CC-479A-8259-3B70F945C7C5Q44899011-5063C5A6-6E30-47A5-AE5D-16129A95718BQ58754943-1947E12C-C9F7-4AD3-B8B5-A789959AA700
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Post-transplant hemolytic-uremic syndrome.
@ast
Post-transplant hemolytic-uremic syndrome.
@en
type
label
Post-transplant hemolytic-uremic syndrome.
@ast
Post-transplant hemolytic-uremic syndrome.
@en
prefLabel
Post-transplant hemolytic-uremic syndrome.
@ast
Post-transplant hemolytic-uremic syndrome.
@en
P1433
P1476
Post-transplant hemolytic-uremic syndrome.
@en
P2093
Piero Ruggenenti
P304
P356
10.1046/J.1523-1755.2002.00543.X
P407
P577
2002-09-01T00:00:00Z
P5875
P6179
1008858492